Kala Pharmaceuticals, Inc.·4

Jun 17, 4:45 PM ET

Rosen Howard B 4

4 · Kala Pharmaceuticals, Inc. · Filed Jun 17, 2022

Insider Transaction Report

Form 4
Period: 2022-06-16
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-16+40,00040,000 total
    Exercise: $0.36Exp: 2032-06-15Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022.

Documents

1 file
  • 4
    form4-06172022_040618.xmlPrimary